{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:43:36Z","timestamp":1790052216662,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.compbiolchem.2024.108049","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T01:18:20Z","timestamp":1710119900000},"page":"108049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["In silico exploration of CB2 receptor agonist in the management of neuroinflammatory conditions by pharmacophore modeling"],"prefix":"10.1016","volume":"110","author":[{"given":"Shlok","family":"Bodke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1503-5006","authenticated-orcid":false,"given":"Nachiket","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajasekhar Reddy","family":"Alavala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1741-4838","authenticated-orcid":false,"given":"Divya","family":"Suares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.compbiolchem.2024.108049_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/ijms18040691","article-title":"(\u2212)-\u03b2-Caryophyllene, a CB2 receptor-selective phytocannabinoid, suppresses motor paralysis and neuroinflammation in a murine model of multiple sclerosis","volume":"18","author":"Alberti","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.compbiolchem.2024.108049_bib2","first-page":"243","article-title":"CB2 cannabinoid receptor as potential target against Alzheimer's disease","volume":"31","author":"Aso P\u00e9rez","year":"2016","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.compbiolchem.2024.108049_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2045125312457586","article-title":"Cannabis, a complex plant: different compounds and different effects on individuals","volume":"2","author":"Atakan","year":"2012","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108049_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/antiox9010021","article-title":"Antioxidative and anti-inflammatory properties of cannabidiol","volume":"9","author":"Atalay","year":"2019","journal-title":"Antioxidants"},{"issue":"W1","key":"10.1016\/j.compbiolchem.2024.108049_bib5","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.compbiolchem.2024.108049_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275765","article-title":"Identification of potential human pancreatic \u03b1amylase inhibitors from natural products by molecular docking, MM\/GBSA calculations, MD simulations, and ADMET analysis","volume":"18","author":"Basnet","year":"2023","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.compbiolchem.2024.108049_bib7","doi-asserted-by":"crossref","DOI":"10.1063\/5.0020514","article-title":"Pressure control using stochastic cell rescaling","volume":"153","author":"Bernetti","year":"2020","journal-title":"J. Chem. Phys."},{"issue":"4","key":"10.1016\/j.compbiolchem.2024.108049_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/ACO.0000000000000616","article-title":"An overview of the cannabinoid type 2 (CB2) receptor system and its therapeutic potential","volume":"31","author":"Bie","year":"2018","journal-title":"Curr. Opin. Anaesthesiol."},{"issue":"8","key":"10.1016\/j.compbiolchem.2024.108049_bib9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ar.23587","article-title":"Neuroplasticity of supraspinal structures associated with pathological pain","volume":"300","author":"Boadas-Vaello","year":"2017","journal-title":"Anat. Rec."},{"issue":"7","key":"10.1016\/j.compbiolchem.2024.108049_bib10","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.bmc.2015.01.059","article-title":"Cannabidiol (CBD) and its analogs: a review of their effects on inflammation","volume":"23","author":"Burstein","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108049_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.compbiolchem.2024.108049_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.mcn.2006.12.005","article-title":"Excitotoxicity in a chronic model of multiple sclerosis: neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation","volume":"34","author":"Docagne","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.compbiolchem.2024.108049_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/14728222.12.2.185","article-title":"Therapeutic potential of CB2 targeting in multiple sclerosis","volume":"12","author":"Docagne","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.compbiolchem.2024.108049_bib14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11481-014-9556-y","article-title":"\u03b2-Arrestin 2 mediates the anti-inflammatory effects of fluoxetine in lipopolysaccharide-stimulated microglial cells","volume":"9","author":"Du","year":"2014","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11030-009-9166-4","article-title":"A computational study on cannabinoid receptors and potent bioactive cannabinoid ligands: homology modeling, docking, de novo drug design and molecular dynamics analysis","volume":"14","author":"Durdagi","year":"2010","journal-title":"Mol. Divers."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108049_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/prot.10001","article-title":"Evaluation of a fast implicit solvent model for molecular dynamics simulations","volume":"46","author":"Ferrara","year":"2002","journal-title":"Protein.: Struct., Funct., Bioinforma."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108049_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.phrs.2012.11.002","article-title":"Cannabinoid agonists increase the interaction between \u03b2-Arrestin 2 and ERK1\/2 and upregulate \u03b2-Arrestin 2 and 5-HT2A receptors","volume":"68","author":"Franklin","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2014.12.003","article-title":"Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson\u2019s disease","volume":"587","author":"Garc\u00eda","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"5800","key":"10.1016\/j.compbiolchem.2024.108049_bib19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of Alzheimer's disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.compbiolchem.2024.108049_bib20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jcc.10379","article-title":"Converging free energy estimates: MM-PB(GB)SA studies on the protein\u2212protein complex Ras\u2212Raf","volume":"25","author":"Gohlke","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"10","key":"10.1016\/j.compbiolchem.2024.108049_bib21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1101\/lm.1893710","article-title":"Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat","volume":"17","author":"Goonawardena","year":"2010","journal-title":"Learn. Mem."},{"issue":"4","key":"10.1016\/j.compbiolchem.2024.108049_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cell.2020.01.008","article-title":"Activation and signaling mechanism revealed by cannabinoid receptor-Gi complex structures","volume":"180","author":"Hua","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108049_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/can.2016.0037","article-title":"Cannabinoid CB1 and CB2 receptor signaling and bias","volume":"2","author":"Ibsen","year":"2017","journal-title":"Cannabis cannabinoid Res."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fphar.2019.00350","article-title":"Cannabinoid CB1 and CB2 receptor-mediated arrestin translocation: species, subtype, and agonist-dependence","volume":"10","author":"Ibsen","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"16","key":"10.1016\/j.compbiolchem.2024.108049_bib25","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.3390\/ijms22168961","article-title":"The CB2 receptor as a novel therapeutic target for epilepsy treatment","volume":"22","author":"Ji","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.compbiolchem.2024.108049_bib26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1124\/jpet.109.159145","article-title":"Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo","volume":"332","author":"Jones","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fncel.2016.00294","article-title":"Cannabinoid receptors in the central nervous system: their signaling and roles in disease","volume":"10","author":"Kendall","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.compbiolchem.2024.108049_bib28","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3390\/ijms23020975","article-title":"New insights and potential therapeutic targeting of CB2 cannabinoid receptors in CNS disorders","volume":"23","author":"Kibret","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"W1","key":"10.1016\/j.compbiolchem.2024.108049_bib29","doi-asserted-by":"crossref","first-page":"W409","DOI":"10.1093\/nar\/gks378","article-title":"ZINCPharmer: pharmacophore search of the ZINC database","volume":"40","author":"Koes","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.compbiolchem.2024.108049_bib30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jmgm.2009.01.004","article-title":"Comparative structural studies of psychrophilic and mesophilic protein homologues by molecular dynamics simulation","volume":"27","author":"Kundu","year":"2009","journal-title":"J. Mol. Graph. Model."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108049_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.compbiolchem.2024.108049_bib32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2018.12.011","article-title":"Crystal structure of the human cannabinoid receptor CB2","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.compbiolchem.2024.108049_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/mol.117.109355","article-title":"Slowly signaling G protein\u2013biased CB2 cannabinoid receptor agonist LY2828360 suppresses neuropathic pain with sustained efficacy and attenuates morphine tolerance and dependence","volume":"93","author":"Lin","year":"2018","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.compbiolchem.2024.108049_bib34","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3390\/molecules25071622","article-title":"Structure-based site of metabolism (SOM) prediction of ligand for CYP3A4 enzyme: comparison of Glide XP and Induced Fit Docking (IFD)","volume":"25","author":"Lokwani","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108049_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1174-9","article-title":"Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer\u2019s disease","volume":"15","author":"L\u00f3pez","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.compbiolchem.2024.108049_bib36","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.compbiolchem.2024.108049_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcp.2018.07.031","article-title":"Emerging strategies targeting CB2 cannabinoid receptor: biased agonism and allosterism","volume":"157","author":"Morales","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bcp.2018.08.046","article-title":"Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes","volume":"157","author":"Navarro","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104940","article-title":"Pharmacological data of cannabidiol-and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1\/CB2 heteromer receptors","volume":"159","author":"Navarro","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"13","key":"10.1016\/j.compbiolchem.2024.108049_bib40","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.1021\/acs.jmedchem.1c00561","article-title":"Design of negative and positive allosteric modulators of the cannabinoid CB2 receptor derived from the natural product cannabidiol","volume":"64","author":"Navarro","year":"2021","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108049_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/molecules28010044","article-title":"Docking and molecular dynamic investigations of phenylspirodrimanes as cannabinoid receptor-2 agonists","volume":"28","author":"Omar","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.compbiolchem.2024.108049_bib42","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jcim.1c00198","article-title":"Insight into the LFA-1\/SARS-CoV-2 Orf7a Complex by Protein-Protein Docking, Molecular Dynamics, and MM-GBSA Calculations","volume":"61","author":"Ongaro","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib43","article-title":"Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist","author":"Pandey","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib44","first-page":"129","article-title":"Endocannabinoids and aging\u2014inflammation, neuroplasticity, mood and pain","volume":"Vol. 115","author":"Park","year":"2021"},{"issue":"2","key":"10.1016\/j.compbiolchem.2024.108049_bib45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1124\/jpet.108.141994","article-title":"Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats","volume":"327","author":"Rahn","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"14","key":"10.1016\/j.compbiolchem.2024.108049_bib46","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2174\/092986710790980005","article-title":"Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown","volume":"17","author":"Reggio","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"10","key":"10.1016\/j.compbiolchem.2024.108049_bib47","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.eplepsyres.2014.10.001","article-title":"Role of CB2 receptors and cGMP pathway on the cannabinoid-dependent antiepileptic effects in an in vivo model of partial epilepsy","volume":"108","author":"Rizzo","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.yebeh.2016.11.006","article-title":"Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection","volume":"70","author":"Rosenberg","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.841766","article-title":"Cannabinoid CB2 receptors modulate microglia function and amyloid dynamics in a mouse model of Alzheimer\u2019s disease","volume":"13","author":"Ruiz de Mart\u00edn Esteban","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.compbiolchem.2024.108049_bib50","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/acsptsci.9b00049","article-title":"Cannabinoid receptor 2 (CB2) signals via G-alpha-s and induces IL-6 and IL-10 cytokine secretion in human primary leukocytes","volume":"2","author":"Saroz","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"10043","key":"10.1016\/j.compbiolchem.2024.108049_bib51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.compbiolchem.2024.108049_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. -Aided Mol. Des."},{"issue":"10","key":"10.1016\/j.compbiolchem.2024.108049_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076907","article-title":"Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis","volume":"8","author":"Sisay","year":"2013","journal-title":"PloS One"},{"issue":"1-3","key":"10.1016\/j.compbiolchem.2024.108049_bib54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pec.2006.04.007","article-title":"Diabetes education and self-management for ongoing and newly diagnosed (DESMOND): process modelling of pilot study","volume":"64","author":"Skinner","year":"2006","journal-title":"Patient Educ. Couns."},{"issue":"16","key":"10.1016\/j.compbiolchem.2024.108049_bib55","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/jcc.10157","article-title":"Molecular dynamics simulations of the dinuclear zinc-\u03b2-lactamase from Bacteroides fragilis complexed with imipenem","volume":"23","author":"Su\u00e1rez","year":"2002","journal-title":"J. Comput. Chem."},{"issue":"5","key":"10.1016\/j.compbiolchem.2024.108049_bib56","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib57","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB 2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopha.2016.09.044","article-title":"Anti-inflammatory activities of fenoterol through \u03b2-arrestin-2 and inhibition of AMPK and NF-\u03baB activation in AICAR-induced THP-1 cells","volume":"84","author":"Wang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2017.05.044","article-title":"Activation of CB2 receptor system restores cognitive capacity and hippocampal Sox2 expression in a transgenic mouse model of Alzheimer's disease","volume":"811","author":"Wu","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.compbiolchem.2024.108049_bib60","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2020.01.007","article-title":"Cryo-EM structure of the human cannabinoid receptor CB2-Gi signaling complex","volume":"180","author":"Xing","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.compbiolchem.2024.108049_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1874467212666190215112036","article-title":"New insights in cannabinoid receptor structure and signaling","volume":"12","author":"Ye","year":"2019","journal-title":"Curr. Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108049_bib62","first-page":"309","article-title":"Cannabis in Parkinson\u2019s disease: the patients\u2019 view","volume":"11","author":"Yenilmez","year":"2021","journal-title":"J. Park. 'S. Dis."},{"issue":"10","key":"10.1016\/j.compbiolchem.2024.108049_bib63","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1021\/ci4002475","article-title":"MMGBSA As a Tool to Understand the Binding Affinities of Filamin\u2212Peptide Interactions","volume":"53","author":"Ylilauri","year":"2013","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.compbiolchem.2024.108049_bib64","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/molecules27020453","article-title":"In silico prediction and validation of CB2 allosteric binding sites to aid the design of allosteric modulators","volume":"27","author":"Yuan","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.compbiolchem.2024.108049_bib65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13295-011-0018-1","article-title":"Spinal neuroplasticity in chronic pain","volume":"17","author":"Zeilhofer","year":"2011","journal-title":"e-Neuroforum"},{"issue":"11","key":"10.1016\/j.compbiolchem.2024.108049_bib66","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41418-018-0127-2","article-title":"Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of \u03b2-arrestin2 and NLRP3","volume":"25","author":"Zhu","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.compbiolchem.2024.108049_bib67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbi.2020.08.025","article-title":"Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson\u2019s disease model via a \u03b2-arrestin2-biased mechanism","volume":"90","author":"Zhu","year":"2020","journal-title":"Brain, Behav., Immun."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927124000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927124000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T22:43:03Z","timestamp":1716504183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927124000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":67,"alternative-id":["S1476927124000379"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108049","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico exploration of CB2 receptor agonist in the management of neuroinflammatory conditions by pharmacophore modeling","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108049"}}